By Tony Fong

NEW YORK (GenomeWeb News) – Scientists from the University of Toronto have launched a new instrument combining flow cytometry and atomic mass spectrometry that they say can quantify biomarkers in parallel in numbers not achievable with other technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.